Globus Medical, Inc. (GMED) Financials

GMED Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 5.4 billion 707.2 million
Dec. 31, 2025 5.3 billion 729.5 million
Sept. 30, 2025 5.1 billion 696.8 million
June 30, 2025 5.0 billion 665.4 million

GMED Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 162.7 million 12.6 million
Dec. 31, 2025 192.4 million 11.4 million
Sept. 30, 2025 218.9 million 11.5 million
June 30, 2025 31.3 million 13.6 million

GMED Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 124.3 million
Dec. 31, 2025 140.6 million
Sept. 30, 2025 119.0 million
June 30, 2025 202.8 million

GMED Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 629.9 million 100.1 million 115.2 million
Dec. 31, 2025 557.2 million 103.9 million 118.7 million
Sept. 30, 2025 390.5 million - 105.0 million
June 30, 2025 229.4 million - 121.1 million

GMED Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 138.2 million
Dec. 31, 2025 137.2 million
Sept. 30, 2025 135.4 million
June 30, 2025 136.5 million

GMED Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 39.6 million 36.5 million 297.8 million -
Dec. 31, 2025 56.2 million 73.9 million 456.3 million -
Sept. 30, 2025 30.8 million 38.1 million 313.6 million -
June 30, 2025 46.6 million 40.0 million 303.6 million -

GMED Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 759.9 million 234.1 million
Dec. 31, 2025 826.4 million 231.3 million
Sept. 30, 2025 769.0 million 282.4 million
June 30, 2025 745.3 million 248.8 million

GMED Revenue by Segment
Graph available only for paid members. Upgrade to see it.

GMED

Price: $77.95

52 week price:
51.79
101.40

Earnings Per Share: 4.28 USD

P/E Ratio: 17.66

Exchange: NYQ

Sector: Healthcare

Industry: Medical Devices

Country: United States

Volume: 237483

Ebitda: 46.6 million

Market Capitalization: 10.5 billion

Links: